,outcome,arm 1,arm 2
0,intervention,"Capecitabine/docetaxel, docetaxel",
0,"time to disease progression ( TTP ), efficacy","0.652 ; 95 % confidence interval [ CI ] , 0.545 to 0.780, 14.5, 42 %, 6.1",4.2 months
0,efficacy,"0.775 ; 95 % CI , 0.634 to 0.947",NR
0,"time to disease progression ( TTP ), efficacy, total study group","11.5 months, 30 %","11.5 months, 30 %"
